Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Moleculin Biotech Inc
MBRX
Healthcare
Biotechnology
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company. The Company has a pipeline of clinical programs for the treatment of tumors and viruses. It has three core technologies and six drug candidates, three of which have shown human activity in clinical trials. Its core technologies consist of Annamycin, WP1066 Portfolio and WP1122 Portfolio. Annamycin is designed to avoid multidrug...
resistance mechanisms and cardiotoxicity. Its WP1066, is an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers, and WP1220, an analog to WP1066, for the topical treatment of cutaneous T-cell lymphoma. Its portfolio includes WP1193, and WP1220. Its WP1122 contains compounds including WP1096, and WP1097, which is designed to exploit the potential uses of inhibitors of glycolysis such as 2-deoxy-D-glucose (2-DG).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MBRX)
New Post
View:
Posts & Comments
Threaded Posts
(233)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Sep 23, 2024 10:32am
Moleculin Announces Positive In Vivo Efficacy Data of Annamy
JUST IN: $MBRX Moleculin Announces Positive In Vivo Efficacy Data of Annamycin in Orthotopic and Experimental Lung Metastatic Models of SarcomaMoleculin Announces Positive In Vivo Efficacy Data of
...more
(233)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Sep 09, 2024 9:00pm
Moleculin Announces First Patients Treated in Phase 2 Clinic
BREAKING NEWS: $MBRX Moleculin Announces First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of GlioblastomaMoleculin Announces First
...more
QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
posted Nov 25, 2024 9:00am by
Q Precious & Battery Metals Corp.
-
|
The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more
(35)
•••
Dormie18
X
View Profile
View Bullboard History
Comment by
Dormie18
on Jul 04, 2024 9:55pm
RE:Moleculin Announces 2023 Year-End Annamycin Clinical Trials
Klemp said a meeting with the FDA had been scheduled for June to discuss the results to date for MB-106 and design the Phase 2B/3 trial which might start as early as late 2024. Klemp said he would
...more
(233)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jan 24, 2024 2:00pm
Moleculin Announces 2023 Year-End Annamycin Clinical Trials
News; $MBRX Moleculin Announces 2023 Year-End Annamycin Clinical Trials Preliminary Data and 2024 Expectations for Multiple Data Readouts and Transition to Pivotal Phase 2B/3Moleculin Announces 2023
...more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 18, 2023 3:48pm
MBRX..... What a Deal !!!!!!!!!!!!!!
NR..... Chasers buy it up...........then the big DUMP !!!!
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 18, 2023 2:15pm
MBRX.... I fail to mention that.....
Nr's that get announced after the opening bell ....seldom workout JMHO
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 18, 2023 1:53pm
MBRX .... Pop on NR
On watch
(10)
•••
Blocky
X
View Profile
View Bullboard History
Comment by
Blocky
on Jan 10, 2021 10:29am
RE:Moleculin + WPD Pharma
Look forward to next week! News expected!?
(10)
•••
Blocky
X
View Profile
View Bullboard History
Post by
Blocky
on Jan 08, 2021 10:17am
Moleculin + WPD Pharma
Covid19-drug-news coming soon!? Moleculin + WPD Pharma could be tenbaggers this year :-) With their WP1122 they could rule the world! Is it really the only Covid19-drug worldwide?
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income